Low-dose Rituximab therapy for neuromyelitis optica spectrum disorders

被引：0
|
作者：
Novo, A. [1 ]
Correia, I. [1 ]
Marques, I. [1 ]
Batista, S. [1 ]
Sousa, L. [1 ]
机构：
[1] CHUC, Neurol, Coimbra, Portugal
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P22112
引用
收藏
页码：542 / 542
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF FIXED HIGH DOSE WITH VARIABLE LOW DOSE RITUXIMAB IN NEUROMYELITIS OPTICA SPECTRUM DISORDERS
    Kelly, Patricia
    Whittam, Daniel
    Linaker, Samantha
    Mutch, Kerry
    Karthikeayan, Venkatraman
    Huda, Saif
    Jacob, Anu
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E16 - E16
  • [2] Clinical course, safety of low-dose rituximab for vietnameses patients with neuromyelitis optica spectrum disorder
    Le, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 83 - 83
  • [3] Retrospective Observation of Low-Dose Rituximab Treatment in Chinese Patients With Neuromyelitis Optica Spectrum Disorders in a Real-World Setting
    Xiao, Haibing
    Zeng, Wenshuang
    Li, Ling
    Li, Lina
    Cui, Yuzhen
    Wang, Jie
    Ye, Jinhao
    Yang, Qingyan
    [J]. FRONTIERS IN NEUROLOGY, 2020, 11
  • [4] Low-dose tacrolimus in treating neuromyelitis optica spectrum disorder
    Wang, Liang
    Tan, Hongmei
    Huang, Wenjuan
    ZhangBao, Jingzi
    Chang, Xuechun
    Zhou, Lei
    Lu, Chuanzhen
    Wang, Min
    Lu, Jiahong
    Zhao, Chongbo
    Quan, Chao
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 48
  • [5] Individualized Rituximab Treatment for Neuromyelitis Optica Spectrum Disorders
    McKeon, Andrew
    Pittock, Sean
    [J]. JAMA NEUROLOGY, 2013, 70 (09) : 1102 - 1104
  • [6] Rituximab in Neuromyelitis Optica Spectrum Disorders: Our Experience
    Jade, Jui Dilip
    Bansi, Srishti
    Singhal, Bhim
    [J]. ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2017, 20 (03) : 229 - 232
  • [7] Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders
    Ciron, J.
    Audoin, B.
    Bourre, B.
    Brassat, D.
    Durand-Dubief, F.
    Laplaud, D.
    Maillart, E.
    Papeix, C.
    Vukusic, S.
    Zephir, H.
    Marignier, R.
    Collongues, N.
    [J]. REVUE NEUROLOGIQUE, 2018, 174 (04) : 255 - 264
  • [8] Psoriasis induced by Rituximab in Neuromyelitis Optica Spectrum Disorders
    Cheng, S.
    Li, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP94 - NP94
  • [9] Clinical and biochemical evaluation of rituximab as add on therapy in neuromyelitis optica spectrum disorders
    Ding, Chawen
    Zheng, Lei
    Xiong, Mingjian
    Zhang, Dongping
    Chen, Zhongmei
    Wang, Linge
    Luo, Zhihua
    Qiao, Hong
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024,
  • [10] Efficacy of Low-Dose Rituximab on Neuromyelitis Optica-Associated Optic Neuritis
    Zhao, Shuo
    Zhou, Huanfen
    Xu, Quangang
    Dai, Hong
    Wei, Shihui
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
12345